Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer

V. C. Dieras, H. S. Han, B. Kaufman, H. Wildiers, M. Friedlander, J-P. Ayoub, S. L. Puhalla, I. Bondarenko, M. Campone, E. H. Jakobsen, M. Jalving, C. Oprean, M. Palacova, Y. H. Park, Y. Shparyk, E. Yanez, M. Dudley, C. K. Ratajczak, D. Maag, B. K. Arun

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerLBA9
TidsskriftAnnals of Oncology
Vol/bind30
Udgave nummerSuppl. 5
Sider (fra-til)857-858
ISSN0923-7534
DOI
StatusUdgivet - okt. 2019
Begivenhed44th Congress of the European Society for Medical Oncology - Barcelona, Spanien
Varighed: 27. sep. 20191. okt. 2019

Konference

Konference44th Congress of the European Society for Medical Oncology
LandSpanien
ByBarcelona
Periode27/09/201901/10/2019

Citationsformater

Dieras, V. C., Han, H. S., Kaufman, B., Wildiers, H., Friedlander, M., Ayoub, J-P., Puhalla, S. L., Bondarenko, I., Campone, M., Jakobsen, E. H., Jalving, M., Oprean, C., Palacova, M., Park, Y. H., Shparyk, Y., Yanez, E., Dudley, M., Ratajczak, C. K., Maag, D., & Arun, B. K. (2019). Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer. Annals of Oncology, 30(Suppl. 5), 857-858. [LBA9]. https://doi.org/10.1093/annonc/mdz394.008